Impact

Advanced search
1 - 20 out of 346Page size: 20
Sort by: Created date

  1. Haiyu Li REF2021 Impact Case

    Darren Clement (Participant), Haiyu Li (Participant)

    Impact

  2. Zhongdong Wang REF2021 Impact Case

    Darren Clement (Participant), Zhongdong Wang (Participant)

    Impact

  3. Peter Crossley REF2021 Impact Case

    Darren Clement (Participant), Peter Crossley (Participant)

    Impact

  4. REF2021 Impact Case

    Darren Clement (Participant)

    Impact

  5. R v B. (London, 2019)

    Eithne Quinn (Participant)

    Impact

  6. R v J. (London, 2019)

    Eithne Quinn (Participant)

    Impact

  7. Member of International Consensus Guidelines Committee for the Prevention of Violent Radicalization and Extremist Violence of the Canadian Practitioners Network for the Prevention of Radicalization and Extremist Violence (CPN-PREV), February 2019-

    Hilary Pilkington (Participant)

    Impact: Societal impacts

  8. All Party Parliamentary Group on British Muslims

    Saskia Warren (Participant)

    Impact

  9. Coordination models for Optimising Flexibility

    Nikolay Mehandjiev (Participant)

    Impact: Economic impacts

  10. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

    Silke Gillessen Sommer (Participant)

    Impact: Health impacts

  11. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer

    Silke Gillessen Sommer (Participant)

    Impact: Health impacts

  12. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage

    Silke Gillessen Sommer (Participant)

    Impact: Health impacts

  13. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

    Silke Gillessen Sommer (Participant)

    Impact: Health impacts

  14. Management of Patients with Advanced Prostate Cancer: The report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen Sommer (Participant)

    Impact: Health impacts

  15. Implementation of TIL therapy in Ovarian Cancer

    Richard Edmondson (Participant), Gordon Jayson (Participant)

    Impact: Health impacts

  16. A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation

    Peter Hoskin (Participant), Angela R. McLean (Participant), Ella K Adlen (Participant), Elisabeth Cardis (Participant), Dudley T Goodhead (Participant), Mats Harms-Ringdahl (Participant), JH. Hendry (Participant), Penny A. Jeggo (Participant), DJC Mackay (Participant), Colin R Muirhead (Participant), J Shepherd (Participant), R. E. Shore (Participant), GA Thomas (Participant), R Wakeford (Participant), H. Charles J Godfray (Participant)

    Impact

  17. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer

    Peter Hoskin (Participant), Carl Salembier (Participant), Geert Villeirs (Participant), B De Bari (Participant), Bradley R Pieters (Participant), Marco van Vulpen (Participant), V Khoo (Participant), A Henry (Participant), Alberto Bossi (Participant), Gert De Meerleer (Participant), Valérie Fonteyne (Participant)

    Impact

  18. Non-Hodgkin’s lymphoma: diagnosis and management NICE guideline [NG52]

    Peter Hoskin (Participant)

    Impact

  19. NICE Prostate cancer: diagnosis and management clinical guideline [CG175]

    Peter Hoskin (Participant)

    Impact

  20. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update.

    Peter Hoskin (Participant), A. Colombo (Participant), A Henry (Participant), P Niehoff (Participant), Taran Paulsen Hellebust (Participant), Frank-Andre Siebert (Participant), G Kovacs (Participant)

    Impact

Previous 1 2 3 4 5 6 7 8 ...18 Next